Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exacerbations and Real-World Outcomes Among Chronic Obstructive Pulmonary Disease Patients Receiving Breztri (EROS Study)

NCT06514144 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06514144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06514144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exacerbations and Real-World Outcomes Among Chronic Obstructive Pulmonary Disease Patients Receiving Breztri (EROS Study)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 1, 2022
Completion date
March 7, 2023
Enrollment
2,409 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive, pulmonary disease, retrospective studies